Permanent aspirin in small doses for at least six months significantly reduces the risk of cancer, Chinese researchers said, quoted by the British daily Daily Express.
The large-scale study was conducted by Hong Kong University Chinese specialists. More than 600,000 people participated in it.
It turned out that aspirin is particularly effective against those oncological diseases that affect the digestive system of the human body. The risk of liver and oesophageal cancer decreases by 47 percent with regular aspirin.
There is also a risk of 38% cancer of the stomach, 34% cancer of the pancreas and 24% cancer of the colon. Prolonged aspirin in amounts of 80 milligrams a day can significantly reduce the number of cancers of the digestive system.
Similar findings are also seen with other types of cancer that are unrelated to it. It’s about such oncological forms as leukemia, lung cancer, and prostate cancer. Aspirin reduces their risk by 24, 35 and 14 percent, respectively.